News

Powered Research, a leading preclinical CRO specializing in non-GLP models, has launched its oncology models and research services tailored to meet the unique needs of life science R&D companies. This ...
A genetically engineered pig kidney helped Towana Looney enjoy 130 days without the need for dialysis before the organ was ...
A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an adolescent with progressive SETTLE tumor. Target identification combined with pre ...
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for HER2-Amplified Advanced Biliary Tract Cancer We report on interview data collected from a ...
Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...
LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding ...
The FDA cleared the investigational new drug application for ALX2004, with phase 1 trials expected to begin in mid-2025 for ...
“Although the xenograft could secrete bile and produce porcine albumin in this study, it is unlikely that the production of bile and porcine albumin was enough to support the human body for a ...
Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...
Her case will continue to add to the scientific community’s understanding of xenotransplantation, from the initial transplant procedure to the post-transplant management of the xenograft,” the ...